logo

ST Pharm

231, Hyupryeok-ro, Siheung-si, Gyeonggi-do, Republic of Korea


Update Date : 2026-04-01
Company information
Related News

  • ST PHARM is a pioneer in manufacturing RNA based drugs. Established in 1983, ST PHARM is offering top custom manufacturing services for active pharmaceutical ingredient and intermediates in compliance to cGMP to fulfill the client’s high expectations for the use of our products in pharmaceutical development and commercialization. Well-proven through decades of business relationships with many big pharmaceutical companies and bio-techs, our reliability in service is the essence of our strength along with our expertise in process development and scale-up optimization.
  • Small molecule : High profile GMP integrity / A proven API partner from development to launch / Strong track record in anti-viral APIs / One-stop service from Process / Analytical, CMC Oligoneucleotide : Global top-3 positioned service / Fully Integrated capability / Sugars, Nucleosides to Phosphoramidites mRNA : Strong IP position of ST PHARM's SMARTCAP® using novel capping analogues.
  • Public
  • Pharma, CDMO, R&D Service, Bio
  • Code
    Phase II
    Undisclosed
    HIV
    Code
    Phase I
    Undisclosed
    Colorectal cancer
Copyright ⓒ BQURA, Mediandshare 2024

Publisher-Editor : Wan Ju (Jay) Kim

Address : 919, 33, International Finance Road 6-gil, Yeongdeungpo-gu, Seoul, Korea

Tel : 82-10-9336-6304 / bqura.adm@gmail.com

Copyright ⓒ BQURA, Mediandshare 2024

BQURA